Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG)

Annals of Oncology

Volumn 22, Issue 4, 2011, Pages 827-834

  Kosmidis, P A ^a   Fountzilas, G ^b   Eleftheraki, A G ^c   Kalofonos, H P ^d   Pentheroudakis, G ^e   Skarlos, D ^f   Dimopoulos, M A ^g   Bafaloukos, D ^f   Pectasides, D ^h   Samantas, E ⁱ   Boukovinas, J ^j   Lambaki, S ^b   Katirtzoglou, N ^k   Bakogiannis, C ^a   Syrigos, K N ^k  

^a HYGEIA HOSPITAL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Hellenic Cooperative Oncology Group   (Greece)

^d UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

^f METROPOLITAN HOSPITAL   (Greece)

^g UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^h NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

ⁱ AGII ANARGIRI CANCER HOSPITAL   (Greece)

^j Theagenio Hospital   (Greece)

^k SOTIRIA GENERAL HOSPITAL   (Greece)

more..

Author keywords

Chemotherapy; Gemcitabine; NSCLC; Paclitaxel; Vinorelbine

Indexed keywords

CIMETIDINE; DEXAMETHASONE; DIPHENHYDRAMINE; GEMCITABINE; NAVELBINE; ONDANSETRON; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD TOXICITY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HEART ARRHYTHMIA; HUMAN; INFECTION; LEUKOPENIA; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

EID: 79953302404     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq445     Document Type: Article

References (15)

1. Ginsberg RJ, Vokes EE, Rosenzweig K. Non small cell lung cancer. In De Vita VT Jr, Hellman S, Rosenber SR (eds), Cancer: Principles and Practice of Oncology, 6th edition. Philadelphia, PA: Lippinicott-Raven 2001; 925-983.
2. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995; 311: 899-909.
3. Cullen MH, Billingham LJ, Woodroffe CM et al. Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 1999; 17: 3188-3194.
4. Kosmidis P, Mylonakis N, Nicolaides C et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol 2002; 20: 3578-3585.
5. Kosmidis P, Kalofonos H, Christodoulou C et al. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group. Ann Oncol 2008; 19: 115-122.
6. Georgoulias V, Papadakis E, Alexopoulos A et al. Platinum-based and nonplatinum-based chemotherapy in advanced non-small-cell lung cancer: a randomized multicentre trial. Lancet 2001; 357: 1478-1484.
7. Schiller JH, Harrington D, Belani C et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002; 346: 92-98.
8. Photiou A, Shah P, Leong LK et al. In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma lines. Eur J Cancer 1997; 33(3): 463-470.
9. Budman DR, Calabro A, Wang LG et al. Synergism of cytotoxic effect of vinorelbine and paclitaxel in vitro. Cancer Invest 2000; 18(8): 804-805.
10. Cohen RB, Mueller SC, Haden K et al. Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer. Cancer Invest 2000; 18(5): 498-500.
11. Ginopoulos P, Kontomanolis E, Kardamakis D et al. A phase II study of nonplatinum based chemotherapy with paclitaxel and vinorelbine in non-small cell lung cancer. Lung Cancer 2002; 38(2): 199-203.
12. Stathopoulos GP, Veslemes M, Georgatou N et al. Paclitaxel and vinorelbine combination in advanced inoperable adenocarcinoma of the lung: a phase II study. Anticancer Res 2003; 23(4): 3479-3484.
13. Sandler A, Gray R, Perry M et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med 2005; 355: 2542-2550.
14. Moher D. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. JAMA 1998; 279: 1489-1491.
15. D'Addario G, Pintilie M, Leighl N et al. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer. A meta-analysis of the published literature. J Clin Oncol 2005; 23: 2926-2936.